Sequential oncological therapy and delays in oncological diagnostics and treatment
Languages of publication
One of the causes behind the low recovery rate among oncological patients is late diagnosis and delayed treatment. To a large extent it stems from the limited access to standard diagnostic methods, and from the extended waiting time for medical treatment. Delayed diagnosis or commencement of therapy might be patient-related, doctor-related, or might have more to do with the organization of the healthcare system. It would appear that the greatest problem in Poland is the system-related delay. Studies have demonstrated that delayed treatment might have a significant impact on patient survival. Poor health education of the society, lack of comprehensive treatment, and queues for medical care that patients come across virtually at all treatment stages result in neoplastic diseases being diagnosed in their advanced stage only, with delayed treatment lowering the patients’ chances of complete recovery.
- Krajowy Rejestr Nowotworów (KRN; National Cancer Registry). [online: http://onkologia.org.pl/] (access: February 2014).
- Royal College of General Practitioners. Delayed diagnosis of cancer; thematic review. 2010.
- Fundacja Watch Health Care (WHC). [online: http://www.korektorzdrowia.pl/barometr] (access: February 2014).
- Hamilton W: Five misconceptions in cancer diagnosis. Br J Gen Pract 2009; 59(563): 441-5.
- Pawlicki M, Michalczyk A: Badania przyczyn opóźnień leczenia chorych na nowotwory złośliwe (English: Studies on the Causes Behind Treatment Delays in Oncological Patients). Współczesna Onkologia 2005; 9(5): 191-195.
- Jassem J, Ozmen V, Bacanu F, Drobniene M: Delays in diagnosis and treatment of breast cancer: a multinational analysis. Eur J Public Health 2013 [online: doi: 10.1093/eurpub/ckt131].
- Mitchell E, Macdonald S, Campbell N. et al. Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review. Br J Cancer 2008; 98(1): 60-70.
- Allgar V.L., Neal R.D.: Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer Br J Cancer 2005; 92(11): 1959-70.
- Slotman BJ, Cottier B., Bentzen SM et al. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol 2005; 75(3): 349-54.
- Delaney G, Jacob S, Featherstone C, Barton M: The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005; 104(6): 1129-37.
- The NHS Cancer plan: a plan for investment, a plan for reform. Department of Health. 2010.
- Department of Health Cancer Policy Team. Review of waiting times standards. London 2011.
- Richards MA, Westcombe AM, Love SB et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999; 353(9159): 1119-26.
- Smith EC, Ziogas A, Anton-Culver H: Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg 2013; 148(6): 516-23.
- McLaughlin J, Anderson R, Ferketich A et al. Effect on Survival of Longer Intervals Between Confirmed Diagnosis and Treatment Initiation Among Low-Income Women With Breast Cancer J Clin Oncol 2012; 30(36): 4493-500.
- Chen Z, King W, Pearcey R et al: The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiotherapy and Oncology. 2007: p. 3-16.
- RCGP RCoGP. Delayed diagnosis of cancer; thematic review. 2010.
Publication order reference